An angiotensin II receptor blocker–calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone

The OSCAR study was a multicenter, prospective randomized open-label blinded end-point study of 1164 Japanese elderly hypertensive patients comparing the efficacy of angiotensin II receptor blocker (ARB) uptitration to an ARB plus calcium channel blocker (CCB) combination. In this prospective study,...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Kim-Mitsuyama, Shokei, Ogawa, Hisao, Matsui, Kunihiko, Jinnouchi, Tomio, Jinnouchi, Hideaki, Arakawa, Kikuo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2013
Onderwerpen:
Clinical Trial
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3538966/
https://ncbi.nlm.nih.gov/pubmed/23051740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2012.326
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items